BiotechTube
Home/Werewolf Therapeutics/Daniel J. Hicklin, Ph.D.
DJ

Daniel J. Hicklin, Ph.D.

President, Chief Executive Officer, and Board Member

Werewolf Therapeutics

Therapeutic Areas

Oncology

Werewolf Therapeutics Pipeline

DrugIndicationPhase
WTX-124Advanced or Metastatic Solid TumorsPhase 1/1b
WTX-330Advanced or Metastatic Solid TumorsPhase 1

Leadership Team at Werewolf Therapeutics

SB
Steven Bloom
Chief Business Officer
MU
Michael Urban
Vice President of Finance and Corporate Controller
View full Werewolf Therapeutics profile